Specify a stock or a cryptocurrency in the search bar to get a summary
Cardio Diagnostics Holdings Inc
CDIOCardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois. Address: 311 West Superior Street, Chicago, IL, United States, 60654
Analytics
WallStreet Target Price
2 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CDIO
Dividend Analytics CDIO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CDIO
Stock Valuation CDIO
Financials CDIO
Results | 2019 | Dynamics |